RRC ID 52186
著者 Zhang Y, Long C, Li H, McAnally JR, Baskin KK, Shelton JM, Bassel-Duby R, Olson EN.
タイトル CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.
ジャーナル Sci Adv
Abstract Duchenne muscular dystrophy (DMD), caused by mutations in the X-linked dystrophin gene (DMD), is characterized by fatal degeneration of striated muscles. Dilated cardiomyopathy is one of the most common lethal features of the disease. We deployed Cpf1, a unique class 2 CRISPR (clustered regularly interspaced short palindromic repeats) effector, to correct DMD mutations in patient-derived induced pluripotent stem cells (iPSCs) and mdx mice, an animal model of DMD. Cpf1-mediated genomic editing of human iPSCs, either by skipping of an out-of-frame DMD exon or by correcting a nonsense mutation, restored dystrophin expression after differentiation to cardiomyocytes and enhanced contractile function. Similarly, pathophysiological hallmarks of muscular dystrophy were corrected in mdx mice following Cpf1-mediated germline editing. These findings are the first to show the efficiency of Cpf1-mediated correction of genetic mutations in human cells and an animal disease model and represent a significant step toward therapeutic translation of gene editing for correction of DMD.
巻・号 3(4)
ページ e1602814
公開日 2017-4-1
DOI 10.1126/sciadv.1602814
PII 1602814
PMID 28439558
PMC PMC5389745
MeSH Animals CRISPR-Cas Systems* Dystrophin* / genetics Dystrophin* / metabolism Humans Mice Mice, Inbred mdx Muscular Dystrophy, Animal / genetics Muscular Dystrophy, Animal / metabolism Muscular Dystrophy, Animal / pathology Muscular Dystrophy, Animal / therapy* Muscular Dystrophy, Duchenne / genetics Muscular Dystrophy, Duchenne / metabolism Muscular Dystrophy, Duchenne / pathology Muscular Dystrophy, Duchenne / therapy* Myocytes, Cardiac / metabolism* Myocytes, Cardiac / pathology
IF 13.117
引用数 110
リソース情報
ヒト・動物細胞 HPS0164